U.S. markets open in 1 hour 22 minutes

Mersana Therapeutics, Inc. (MRSN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
13.94-0.16 (-1.13%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 6/24/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 2.43
52-Week Change 3-38.43%
S&P500 52-Week Change 337.70%
52 Week High 329.09
52 Week Low 313.75
50-Day Moving Average 314.51
200-Day Moving Average 318.51

Share Statistics

Avg Vol (3 month) 3628.88k
Avg Vol (10 day) 3855.06k
Shares Outstanding 569.56M
Implied Shares Outstanding 6N/A
Float 54.22M
% Held by Insiders 11.18%
% Held by Institutions 1102.46%
Shares Short (May 27, 2021) 48.45M
Short Ratio (May 27, 2021) 416.44
Short % of Float (May 27, 2021) 413.91%
Short % of Shares Outstanding (May 27, 2021) 412.15%
Shares Short (prior month Apr 29, 2021) 48.27M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin 0.00%
Operating Margin (ttm)-12,750.97%

Management Effectiveness

Return on Assets (ttm)-38.39%
Return on Equity (ttm)-81.07%

Income Statement

Revenue (ttm)828k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)0.00%
Gross Profit (ttm)-66.21M
EBITDA -104.59M
Net Income Avi to Common (ttm)-105.81M
Diluted EPS (ttm)-1.59
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)228.43M
Total Cash Per Share (mrq)3.28
Total Debt (mrq)16.76M
Total Debt/Equity (mrq)8.47
Current Ratio (mrq)6.64
Book Value Per Share (mrq)2.87

Cash Flow Statement

Operating Cash Flow (ttm)-80.47M
Levered Free Cash Flow (ttm)-39.67M